Transcription Factor 3
TCF3geneTCF3 is a transcriptional regulator differentially expressed in type 2 diabetes with CAD, affecting immune cell differentiation.
Pathway placement
Cascade stepPlaque inflammation
Confidencelow
RationaleDifferential marker in T2DM-CAD; adaptive immune pathway regulator; Wnt signaling-related immune differentiation.
Druggability
DruggableNo
Known drugs / candidates0
Small-molecule tractableNo
Antibody tractableNo
EnsemblENSG00000071564
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I33
C — confounder / Type-II81
A — assay feasibility52
E — evidence strength30
T1DI (composite)4
Specificity differential (R−C)-48.1
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Whole blood — gene is not a circulating analyte; measure protein product or genotype
Collection tube
K2-EDTA whole blood (lavender-top)
Method / principle
SNP genotyping / sequencing; or immunoassay of encoded protein
Reagent / substrate
Allele-specific primers/probes (TaqMan) or NGS panel; or antibody for protein
Platform
qPCR / NGS / array
Turnaround · availability
Send-out · Genotyping widely available; protein assay variable
Literature evidence(1)
- Transcriptional profiles associated with coronary artery disease in type 2 diabetes mellitus.Frontiers in endocrinology · 2024 · PMID 38706700 · doi